Actively Recruiting
Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas
Led by Centro di Riferimento Oncologico - Aviano · Updated on 2024-10-01
164
Participants Needed
3
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Artificial intelligence (AI) undoubtedly represents the main tool currently available in the definition of complex algorithms and its use in the medical field is becoming increasingly strategic.As reported in the literature, it is increasingly difficult to find new therapeutic strategies for neoplasms, especially neurological ones. Molecular characterisation is therefore increasingly essential, as is the use of new predictive methods. With this in mind, the aim of this study is to assess, by means of AI algorithms applied to genomic data, in what percentage molecular alterations are susceptible to potential drug therapies, compared to the literature data that does not consider AI algorithms for this purpose.
CONDITIONS
Official Title
Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a histopathological diagnosis of glioma who have biological material preserved by freezing or formalin fixation and paraffin embedding from biopsy, surgery, or blood available for analysis
- Age 18 years or older
- Patients who understand and provide written informed consent
- Life expectancy longer than 3 months
- Biological material from resection and blood considered sufficient in quality and quantity for molecular characterization by the Principal Investigator
- Availability of clinical and histopathological data
You will not qualify if you...
- Refusal to provide informed consent
- Uncooperative patients
- Presence of other cancers diagnosed within the last 5 years
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
Aviano, Pordenone, Italy, 33081
Actively Recruiting
2
IOV
Padova, Italy
Actively Recruiting
3
Azienda Sanitaria Universitaria Friuli Centrale (ASUFC
Udine, Italy, 33100
Actively Recruiting
Research Team
G
Giuseppe Toffoli
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here